Cataract News and Research

Latest Cataract News and Research

Congress needs to replace current outdated Medicare payment system

The Alliance of Specialty Medicine, representing over 100,000 specialty physicians nationwide, released the following statement on Congress's unwillingness to improve and permanently fix the Medicare reimbursement system:

29 May 2010

Amgen announces European approval of Prolia

Amgen Inc. today announced that the European Commission (EC) has granted marketing authorization for Prolia® (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.

28 May 2010

STAAR Surgical to retire 1.7 million preferred shares through cash payment to Canon companies of $6.8M

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported that it will retire 1.7 million preferred shares through a cash payment to the Canon companies of $6.8 million. STAAR originally issued the 1.7 million Series A Convertible Preferred shares as part of the Company's December 2007 purchase of the remaining 50% interest in Canon Staar Co., Inc.

21 May 2010

STAAR Surgical receives CE Mark approval for product improvements to Visian Implantable Collamer Lens

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for a range of product improvements to the Company's Visian Implantable Collamer® Lens (ICL™) that more than doubles the current Visian addressable market in Europe.

20 May 2010

FDA grants LensAR Laser System 510(k) clearance for use in anterior capsulotomy during cataract surgery

LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced that the company has received 510(k) clearance from the FDA for use of the LensAR Laser System for anterior capsulotomy during cataract surgery.

18 May 2010

Phakic IOLs safer than laser surgery for correcting moderate short-sightedness

A new type of procedure for correcting short-sightedness could be safer than laser eye surgery, according to a new Cochrane Systematic Review. The study also shows that patients prefer the new procedure, despite there being little difference between the two in terms of improving vision.

12 May 2010

HOYA reports 26.4% increase in fourth-quarter 2010 net sales

HOYA Corporation today announced financial results for the fourth quarter and fiscal year ended March 31, 2010. Net sales were 104.8 billion yen for the quarter, representing an increase of 26.4% from 82.9 billion yen in the same period last year, mainly due to a recovery in orders in the main business fields such as Electro-Optics, as well as the cost-reduction achieved through structural reform.

7 May 2010

Caffeine is effective in preventing cataract formation, says study

Caffeine may be effective in protecting the lens against damage that could lead to the formation of cataracts, according to a study presented on May 4 at the 2010 Annual Meeting of the Association for Research in Vision and Ophthalmology.

6 May 2010

IBI to present data on Verisome Liquid Drug Delivery System for cystoid macular edema at ARVO 2010

Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it will present an abstract demonstrating the utility of its Verisome™ Liquid Drug Delivery System in cystoid macular edema, at the Association for Research in Vision and Ophthalmology (ARVO) 2010 annual meeting, taking place May 2-6, 2010, in Fort Lauderdale, Florida.

5 May 2010

Landec announces acquisition of Lifecore Biomedical from Warburg Pincus Private Equity

Landec Corporation, a materials science company that develops and markets patented polymer products for food, agriculture, personal care and drug delivery applications, today announced that it has acquired Lifecore Biomedical, Inc. from Warburg Pincus Private Equity IX, LP. When acquired by Warburg Pincus in March 2008, Lifecore was comprised of two divisions, the Dental Division and the Hyaluronan Division. The Dental Division was merged into a Warburg Pincus portfolio company.

3 May 2010

ISTA Pharmaceuticals first-quarter net revenues up 39%

ISTA Pharmaceuticals, Inc., today reported financial results for the quarter ended March 31, 2010. First quarter 2010 net revenues were $28.3 million, an increase of 39% from the first quarter of 2009. Net income for the first quarter ended March 31, 2010, was $0.5 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.59 per share, for the first quarter ended March 31, 2009.

30 Apr 2010

DRCR Network study finds new treatment more effective

28 Apr 2010

Better vision ahead for many diabetic retinopathy patients

A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.

27 Apr 2010

Kaiser Permanente Medical Centers perform 67 outpatient surgeries as part of Free Surgery Day

In partnership with local community health care agencies, three Kaiser Permanente Southern California Medical Centers, opened their doors this morning to perform a total of 67 outpatient surgeries as part of a region-wide Free Surgery Day.

26 Apr 2010

City of Manchester, Anthem Blue Cross and Blue Shield enhance Compass SmartShopper Program

Citing strong interest and engagement from city employees as well as requests from school district members, the city of Manchester and Anthem Blue Cross and Blue Shield in New Hampshire announced today enhancements to the innovative Compass SmartShopper Program as well as the addition of Manchester school district employees to the project.

23 Apr 2010

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

Abbott today announced financial results for the first quarter ended March 31, 2010.

21 Apr 2010

STAAR Surgical reports 12% increase in first-quarter 2010 revenue

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported that revenue for the first quarter ended April 3, 2010 grew approximately 12% as compared to the first quarter of 2009.

13 Apr 2010

Implanting blue light-filtering IOLs during cataract surgery may help preserve retina health

Implanting blue light-filtering intraocular lenses during cataract surgery helps maintain visual function and may preserve the health of the retina, specifically in disease states such as age-related macular degeneration, according to a comprehensive review published in the May/June 2010 edition of Survey of Ophthalmology.

13 Apr 2010

Mylan Pharmaceuticals' ANDA for generic Wellbutrin SR receives FDA final approval

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP, (SR), 100 mg, 150 mg and 200 mg, the generic version of GlaxoSmithKline's antidepressant Wellbutrin SR®.

12 Apr 2010

OptiMedica releases new details on femtosecond laser system for cataract surgery

OptiMedica Corp., a global ophthalmic device company, has released new details regarding the development of its proprietary femtosecond laser system for cataract surgery. The new system, which combines OptiMedica's breakthrough pattern scanning technology, an ultra-fast laser and integrated Optical Coherence Tomography imaging, is designed to dramatically improve the complex cataract procedure by replacing its most technically demanding and manual steps.

12 Apr 2010

Cataract News and Research

Latest Cataract News and Research

Congress needs to replace current outdated Medicare payment system

Amgen announces European approval of Prolia

STAAR Surgical to retire 1.7 million preferred shares through cash payment to Canon companies of $6.8M

STAAR Surgical receives CE Mark approval for product improvements to Visian Implantable Collamer Lens

FDA grants LensAR Laser System 510(k) clearance for use in anterior capsulotomy during cataract surgery

Phakic IOLs safer than laser surgery for correcting moderate short-sightedness

HOYA reports 26.4% increase in fourth-quarter 2010 net sales

Caffeine is effective in preventing cataract formation, says study

IBI to present data on Verisome Liquid Drug Delivery System for cystoid macular edema at ARVO 2010

Landec announces acquisition of Lifecore Biomedical from Warburg Pincus Private Equity

ISTA Pharmaceuticals first-quarter net revenues up 39%

DRCR Network study finds new treatment more effective

Better vision ahead for many diabetic retinopathy patients

Kaiser Permanente Medical Centers perform 67 outpatient surgeries as part of Free Surgery Day

City of Manchester, Anthem Blue Cross and Blue Shield enhance Compass SmartShopper Program

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

STAAR Surgical reports 12% increase in first-quarter 2010 revenue

Implanting blue light-filtering IOLs during cataract surgery may help preserve retina health

Mylan Pharmaceuticals' ANDA for generic Wellbutrin SR receives FDA final approval

OptiMedica releases new details on femtosecond laser system for cataract surgery

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Cataract News and Research

Latest Cataract News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in